Delivery Order SPE2DB20D2104-SPE2DB25FMYGW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract. The award was issued on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $8,055.40 on August 21, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price arrangement. The contract ceiling value is $12,083.10, with an ultimate completion date of October 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a total value of...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. The award was made on July 30, 2025, with an ultimate completion date of August 20, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the delivery from its corporate office location. This delivery order represents a specific...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units). This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of September 26, 2025. The award was issued on September 5, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ingrezza 40 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a ceiling value of $4,027.70. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count) on May 2, 2025, with an ultimate completion date of May 23, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major healthcare solutions provider and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 capsules of Ingrezza 40 mg, a pharmaceutical product used to treat involuntary movement disorders. This firm fixed-price delivery order, valued at $3,676.12, was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYGWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,027.70. The award was made on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement through AmerisourceBergen's existing federal contract framework, with performance to be executed at the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has consistently demonstrated capability to meet DLA medical procurement requirements through open competition across multiple therapeutic domains, from specialty neurological and endocrinology medications to pain management and specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/19/25 |